Christiana Bardon serves as Executive at Spring Bank Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Christiana Bardon has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 1, 2018 involved receiving (via award) 831 shares valued at $0.
Christiana Bardon currently holds 2,296 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christiana Bardon has been a net neutral trader of SBPH stock. They have purchased $0 and sold $0 worth of shares.
Christiana Bardon's most recent insider trade was on Oct 1, 2018, when they sold 831 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 2, 2018 | SBPH | $0 | Award | 641 | $N/A | Discretionary |